✓ Medically Reviewed Monograph

Ipratropium Bromide

Also known as / Synonyms: Ipratropium, SAMA (Short-Acting Muscarinic Antagonist)

Short-acting muscarinic antagonist (SAMA) bronchodilator relieving bronchospasm in COPD and acute asthma.

🩺
Reviewed by Dr. Lisa Matthews, PharmD
Chief Clinical Editor · Updated November 18, 2026 · Editorial & Fact-Checking Policy
CDSCO & FDA Aligned
📋

Clinical Snapshot & Specifications

Generic Name: Ipratropium Bromide
Active Ingredient: Ipratropium Bromide
Dosage Form: Inhaler
Available Strengths: 20 mcg/actuation metered dose inhaler; 250 mcg/mL, 500 mcg/2 mL nebulizer solution
Prescription Status: Prescription only (Schedule H / verified)
Popular Verified Brands:
Ipravent Atrovent Duolin (with Levosalbutamol) Combivent (India)
Regulatory Standards: CDSCO approved; Schedule H prescription drug. Quaternary ammonium anticholinergic bronchodilator.
🎯

Approved Indications & Medical Uses

  • Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
  • Acute bronchospasm in asthma exacerbations (adjunct to short-acting beta-2 agonists).
  • Rhinorrhea associated with allergic or perennial rhinitis (nasal spray formulation).
🚫

Contraindications (Do Not Use If…)

  • Known hypersensitivity to ipratropium bromide, atropine, or other belladonna alkaloids.
  • Known allergy to soya lecithin or peanuts (in older CFC formulations; HFA inhalers generally safe).
🛡️

Important Clinical Precautions & Warnings

  • Paradoxical bronchospasm: may occur immediately after inhalation; discontinue immediately and treat with fast-acting beta-2 agonist.
  • Ocular complications: avoid mist/spray entering eyes; can cause pupil dilation (mydriasis), increased intraocular pressure, and acute angle-closure glaucoma.
  • Urinary retention and prostatic hyperplasia: use with caution in patients with bladder neck obstruction or BPH.
  • Not for rapid monotherapy: onset is slower (15-30 min) than albuterol/levosalbutamol; pair with beta-agonists in acute emergencies.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Approved for acute asthma in nebulized form under medical supervision. Elderly: Increased susceptibility to anticholinergic effects (urinary hesitation, constipation).

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Dry mouth, throat irritation, cough, bitter taste, headache, dizziness, nausea, and mild tachycardia.

🚨 Serious Side Effects — Seek Urgent Medical Care

Acute narrow-angle glaucoma, severe urinary retention, paradoxical bronchospasm, atrial fibrillation/supraventricular tachycardia, and angioedema.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Other anticholinergics (tiotropium, aclidinium, glycopyrronium): additive systemic anticholinergic adverse effects; avoid co-administration.
  • Beta-2 agonists (salbutamol, formoterol): beneficial synergistic bronchodilation without increased adverse events.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Minimal systemic absorption following inhalation; animal reproduction studies show no teratogenicity. Use when clinically needed.

Lactation & Breastfeeding:

Use with caution — see notes

Systemic concentrations are negligible; unlikely to pass into breast milk in detectable quantities.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store inhaler between 20°C and 25°C. Avoid exposing pressurized canister to open flame or temperatures > 50°C.

⏱️ Missed Dose Protocol:

Take standard maintenance dose (2 puffs 4 times daily). If forgotten, take upon remembering unless time for next inhalation.

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.